Abstract
Eight patients with ocular myasthenia gravis unresponsive to anticholines-terase medications were treated with alternate-day prednisone. Seven of the eight showed significant and sustained improvement. The patients exhibited few side effects of steroid therapy, and none manifested neurologic deterioration after institution of the therapy. Since anticholines-terase medications fail to benefit most patients with ocular myasthenia and since these agents reportedly have long-term undesirable effects on the neuromuscular junction, oral prednisone is proposed as an alternative therapy for ocular myasthenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.